EI
HPTX

EAM Investors’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

EAM Investors’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-31,851
Closed -$832K – 410
2013
Q3 		$832K Sell
31,851
-55
-0.2% -$1.38K 0.17% 305
2013
Q2 		$702K Buy
+31,906
New +$699K 0.15% 303

Other funds holding HPTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HMPV
Highland Management Partners VII Cambridge, Massachusetts $5.57M AUM 94.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

EAM Investors's HPTX Position: Q4 2013 in Review

EAM Investors sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q4 2013, closing a stake of 31,851 shares — an estimated $832K sold.

EAM Investors first reported a position in HPTX in Q2 2013 and held it in 2 quarters. The position peaked at $832K in Q3 2013. 61 funds tracked by Wall St. Rank hold HPTX as of Q4 2013.

  • EAM Investors reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • EAM Investors sold 31,851 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q4 2013, an estimated $832K.
  • EAM Investors first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 2 quarters.
  • EAM Investors's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $832K in Q3 2013.
  • 61 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q4 2013.

Based on EAM Investors's 13F filing for Q4 2013, filed 14 Feb 2014.